Renova is a drug owned by Valeant Pharmaceuticals North America Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Mar 07, 2020. Details of Renova's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6531141 | Oil-in-water emulsion containing tretinoin |
Mar, 2020
(4 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Renova is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Renova's family patents as well as insights into ongoing legal events on those patents.
Renova's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Renova's generic launch date based on the expiry of its last outstanding patent is estimated to be Mar 07, 2020 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Renova Generic API suppliers:
Tretinoin is the generic name for the brand Renova. 14 different companies have already filed for the generic of Renova, with Padagis Us having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Renova's generic
Alternative Brands for Renova
There are several other brand drugs using the same active ingredient (Tretinoin) as Renova. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Almirall |
| |||
| Bausch |
| |||
| Concordia |
| |||
| Dow Pharm |
| |||
| Galderma Labs Lp |
| |||
| Sun Pharm |
| |||
| Sun Pharm Inds Inc |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Tretinoin, Renova's active ingredient. Check the complete list of approved generic manufacturers for Renova
About Renova
Renova is a drug owned by Valeant Pharmaceuticals North America Llc. Renova uses Tretinoin as an active ingredient. Renova was launched by Valeant Pharms North in 2000.
Approval Date:
Renova was approved by FDA for market use on 31 August, 2000.
Active Ingredient:
Renova uses Tretinoin as the active ingredient. Check out other Drugs and Companies using Tretinoin ingredient
Dosage:
Renova is available in cream form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.02% | CREAM | Prescription | TOPICAL |